Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Is Wall Street Bullish or Bearish on Charles River Laboratories Stock?

Valued at a market cap of $10.57 billion, Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. The Wilmington, Massachusetts-based company is known for its specialized expertise in drug discovery and development and its comprehensive portfolio of laboratory services.

Shares of this healthcare company have significantly underperformed the broader market over the past 52 weeks. CRL has gained 1.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 27%. In 2024, shares of CRL are down 13.2%, compared to SPX’s 18.1% gains on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.